22/08/2026
๐จ BREAKING IN PHARMA & BIOTECH | WEEK 4 | 22nd August 2026 ๐จ
Zydus Gets FDA Nod | Revance & Teoxane Win Approval for Undereye Hollowing Treatment
๐น Zydus receives final approval from USFDA for ascorbic acid injection
๐น Revance and Teoxane announce the US FDA approval of RHA Redensity Eye for undereye hollowing
๐ From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
๐ฏ Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news โ only on Chemxpert Database.
๐ฅ Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
๐ https://www.youtube.com//videos
๐ฐ Explore more pharma & biotech updates here:
๐ https://chemxpert.com/all-news
๐ Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
๐
Book a demo with Chemxpert Database today:
๐ https://chemxpert.com/demo-request
๐ Visit: www.chemxpert.com
๐ Toll-Free: 1800 4190 155